TAKEDA PHARMACEUTICAL CO LTD·4

Jul 6, 6:05 PM ET

Pacheco Rhonda Janice 4

Research Summary

AI-generated summary

Updated

Takeda (TAK) U.S. President Rhonda Pacheco Receives RSU Award

What Happened Rhonda Janice Pacheco, President of Takeda's U.S. Business Unit, received an award of 50,156 restricted stock units (RSUs) on July 1, 2026. The grant was recorded at an acquisition price of $0.00 in the Form 4 filing (accession 0001395064-26-000252). Each RSU represents a contingent right to receive one American Depositary Share (ADS); the filing does not report an immediate cash purchase or sale.

Key Details

  • Transaction date: July 1, 2026; filing date: July 6, 2026.
  • Transaction type: Award/Grant (code A). Shares granted: 50,156 RSUs at $0.00 (no cash paid at grant).
  • Shares owned after transaction: Not specified in the provided summary of the filing.
  • Footnote: F1 — Each RSU equals a contingent right to one ADS; RSUs vest in three equal annual installments beginning July 1, 2027.
  • No 10b5-1 plan, tax-withholding sale, or late-filing flag was noted in the details provided.

Context This was a compensation award, not an open-market purchase or sale. RSU grants are common for executives and represent future equity contingent on service/vesting; their realized value will depend on Takeda’s ADS market price when the RSUs vest and convert. Awards like this are informative about pay structure but do not, by themselves, indicate insider buying or selling intent.